MicroCare Celebrates Grand Opening of New Warehouse and Distribution Centre

MicroCare™, a leading global manufacturer and distributor of critical cleaning, lubricating and disinfecting products, recently announced the opening of a new warehouse and distribution centre in Leeds, West Yorkshire, England.  The new location will improve service and support of MicroCare distributors and end-users throughout Great Britain, Europe and Africa.   MicroCare also has two logistics centres in the United States and one in Singapore.

The new centre spans 790 square metres and now serves as the primary shipping facility within the U.K. for MicroCare™, MicroCare Medical™ and Sticklers™ cleaning fluids and tools. The new facility will provide access to thousands of SKUs, as well as product staging, kitting, and packing capabilities. It will also serve as the MicroCare U.K. Ltd. office headquarters.

“The new distribution centre represents the MicroCare commitment to best support our customers throughout the region,” says Scott Wells, MicroCare European General Manager. “It was a massive undertaking since the new facility required full renovation and modernisation to make it functional. However, expanding our logistics capabilities in the U.K. streamlines our processes to provide our customers with quicker response and faster shipping times. It also positions us for sustained growth as our customers’ critical cleaning demands continue to evolve.”

For more information, visit microcare.com

Hot this week

Recor Medical Supports European Society of Cardiology’s Hypertension Guidelines

Record Medical notes the new guidelines, "2024 ESC Guidelines for the management of elevated blood pressure and hypertension," have been published online and recommend the consideration of renal denervation (RDN) as a safe and effective treatment option for patients who have uncontrolled resistant hypertension or those that have uncontrolled hypertension with a higher risk of cardiovascular disease, who express a preference to undergo RDN.

ConTIPI Medical Selects EVERSANA to Support U.S. Commercialization of Non-Surgical Medical Device ProVate for Women with Pelvic Organ Prolapse

EVERSANA is a leading provider of global commercial services to the life sciences industry, to support commercialization for the ProVate device in the United States to help women experiencing pelvic organ prolapse.

Boston Scientific Obtains CE Mark for ACURATE Prime Aortic Valve System

The ACURATE Prime aortic valve system is designed with several features to build upon the clinical performance of the ACURATE neo2™ platform including an additional valve size, which expands the treatment range to patients with a larger anatomy.

Noctrix Health Announces New CMS Reimbursement Codes and Payment for Nidra Tonic Motor Activation Therapy for Restless Legs Syndrome

Nidra TOMAC Tonic Motor Activation Therapy, which was authorized for marketing in the United States last year following its designation as a "Breakthrough Device" by the US Food & Drug Administration (FDA), remains the only clinically validated, non-pharmaceutical treatment available for patients with RLS.

Haemonetics Announces Full Market Release for VASCADE MVP® XL Vascular Closure System

Haemonetics notes the VASCADE MVP XL system is now available to U.S. hospitals as the newest addition to Haemonetics' VASCADE® portfolio of vascular closure systems featuring an innovative collapsible disc technology and a proprietary resorbable collagen patch designed to promote rapid hemostasis.